nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessment of the Effects of Renal Impairment on the Pharmacokinetic Profile of Fesoterodine
|
Malhotra, Bimal |
|
2009 |
49 |
4 |
p. 477-482 |
artikel |
2 |
Bioequivalence of 2 Intravenous Amiodarone Formulations in Healthy Participants
|
Cushing, Daniel J. |
|
2009 |
49 |
4 |
p. 407-415 |
artikel |
3 |
Bupropion Has No Effect on Intraocular Pressure or Other Ophthalmologic Parameters After Single or Repeat Doses in Healthy Volunteers
|
Ghibellini, Giulia |
|
2009 |
49 |
4 |
p. 489-495 |
artikel |
4 |
Effect of CP-690,550, an Orally Active Janus Kinase Inhibitor, on Renal Function in Healthy Adult Volunteers
|
Lawendy, Nervin |
|
2009 |
49 |
4 |
p. 423-429 |
artikel |
5 |
Effect of Different Durations of Ketoconazole Dosing on the Single-Dose Pharmacokinetics of Midazolam: Shortening the Paradigm
|
Stoch, S.A. |
|
2009 |
49 |
4 |
p. 398-406 |
artikel |
6 |
Effect of Sitagliptin on the Pharmacokinetics of Simvastatin
|
Bergman, Arthur J. |
|
2009 |
49 |
4 |
p. 483-488 |
artikel |
7 |
Effects of Aspirin When Added to the Prostaglandin D2 Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms
|
Dishy, Victor |
|
2009 |
49 |
4 |
p. 416-422 |
artikel |
8 |
Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects
|
Weijiang Zhang, |
|
2009 |
49 |
4 |
p. 444-454 |
artikel |
9 |
Influence of Liver Cirrhosis on the Pharmacokinetics, Pharmacodynamics, and Safety of Tezosentan
|
Dingemanse, Jasper |
|
2009 |
49 |
4 |
p. 455-464 |
artikel |
10 |
Kerfuffle!
|
Grasela, Thaddeus H. |
|
2009 |
49 |
4 |
p. 386-388 |
artikel |
11 |
Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
|
Marbury, Thomas |
|
2009 |
49 |
4 |
p. 465-476 |
artikel |
12 |
Similar Rivastigmine Pharmacokinetics and Pharmacodynamics in Japanese and White Healthy Participants Following the Application of Novel Rivastigmine Patch
|
Lefèvre, Gilbert |
|
2009 |
49 |
4 |
p. 430-443 |
artikel |
13 |
The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
|
Böhmer, Gabriele M. |
|
2009 |
49 |
4 |
p. 389-397 |
artikel |